These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34904611)

  • 21. Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.
    Pender A; Garcia-Murillas I; Rana S; Cutts RJ; Kelly G; Fenwick K; Kozarewa I; Gonzalez de Castro D; Bhosle J; O'Brien M; Turner NC; Popat S; Downward J
    PLoS One; 2015; 10(9):e0139074. PubMed ID: 26413866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.
    Vessies DCL; Greuter MJE; van Rooijen KL; Linders TC; Lanfermeijer M; Ramkisoensing KL; Meijer GA; Koopman M; Coupé VMH; Vink GR; Fijneman RJA; van den Broek D
    Sci Rep; 2020 May; 10(1):8122. PubMed ID: 32415199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution melting analysis for genotyping Duffy blood group antigens.
    Łukasik E; Waśniowska K; Grodecka M; Majorczyk E; Czerwiński M
    Methods Mol Biol; 2015; 1310():83-95. PubMed ID: 26024627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
    Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
    Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
    Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
    BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex Detection of KRAS Mutations Using Passive Droplet Fusion.
    Pekin D; Taly V
    Methods Mol Biol; 2017; 1547():133-142. PubMed ID: 28044293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer.
    Botezatu IV; Kondratova VN; Shelepov VP; Mazurenko NN; Tsyganova IV; Susova OY; Lichtenstein AV
    Anal Biochem; 2020 Feb; 590():113517. PubMed ID: 31782995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation.
    Kang Q; Parkin B; Giraldez MD; Tewari M
    Biotechniques; 2016 Apr; 60(4):175-6, 178, 180 passim. PubMed ID: 27071606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA.
    Hussung S; Follo M; Klar RFU; Michalczyk S; Fritsch K; Nollmann F; Hipp J; Duyster J; Scherer F; von Bubnoff N; Boerries M; Wittel U; Fritsch RM
    J Mol Diagn; 2020 Jul; 22(7):943-956. PubMed ID: 32376474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-the-Fly Mass Spectrometry in Digital Microfluidics Enabled by a Microspray Hole: Toward Multidimensional Reaction Monitoring in Automated Synthesis Platforms.
    Das A; Weise C; Polack M; Urban RD; Krafft B; Hasan S; Westphal H; Warias R; Schmidt S; Gulder T; Belder D
    J Am Chem Soc; 2022 Jun; 144(23):10353-10360. PubMed ID: 35640072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer.
    Huang F; Yang Y; Chen X; Jiang H; Wang H; Shen M; Yu Y; Liu T; Pan B; Wang B; Guo W
    Clin Biochem; 2021 Jun; 92():46-53. PubMed ID: 33737000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.
    Kristensen LS; Daugaard IL; Christensen M; Hamilton-Dutoit S; Hager H; Hansen LL
    Hum Mutat; 2010 Dec; 31(12):1366-73. PubMed ID: 20848649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
    Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
    Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate zygote-specific discrimination of single-nucleotide polymorphisms using microfluidic electrochemical DNA melting curves.
    Yang AH; Hsieh K; Patterson AS; Ferguson BS; Eisenstein M; Plaxco KW; Soh HT
    Angew Chem Int Ed Engl; 2014 Mar; 53(12):3163-7. PubMed ID: 24520069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.
    Kristensen LS; Andersen GB; Hager H; Hansen LL
    Hum Mutat; 2012 Jan; 33(1):264-71. PubMed ID: 21901793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kras gene codon 12 mutation detection enabled by gold nanoparticles conducted in a nanobioarray chip.
    Sedighi A; Li PC
    Anal Biochem; 2014 Mar; 448():58-64. PubMed ID: 24291640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel high-speed droplet-allele specific-polymerase chain reaction: application in the rapid genotyping of single nucleotide polymorphisms.
    Taira C; Matsuda K; Yamaguchi A; Sueki A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
    Clin Chim Acta; 2013 Sep; 424():39-46. PubMed ID: 23685227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E; Jurado I; Hernan I; Gamundi MJ; Dias M; Martí I; Mañé B; Arcusa A; Agúndez JA; Blanca M; Carballo M
    BMC Cancer; 2011 Sep; 11():406. PubMed ID: 21943394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.
    Denis JA; Patroni A; Guillerm E; Pépin D; Benali-Furet N; Wechsler J; Manceau G; Bernard M; Coulet F; Larsen AK; Karoui M; Lacorte JM
    Mol Oncol; 2016 Oct; 10(8):1221-31. PubMed ID: 27311775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
    Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
    Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.